CBAY - CymaBay Therapeutics Inc.'s (CBAY) CEO Sujal Shah on Q2 2020 Results - Earnings Call Transcript
CymaBay Therapeutics, Inc. (CBAY)
Q2 2020 Results Earnings Conference Call
August 10, 2020, 4:30 PM ET
Company Participants
Dan Menold - Vice President, Finance
Sujal Shah - Chief Executive Officer
Dr. Chuck McWherter - Chief Scientific Officer
Klara Dickinson - Chief Regulatory and Compliance Officer
Conference Call Participants
Steve Seedhouse - Raymond James
Eliana Merle - Cantor Fitzgerald
Ed Arce - H.C. Wainwright
Jay Olson - Oppenheimer
Thomas Smith - SVB Leerink
Presentation
Operator
Greetings. And welcome to CymaBay Therapeutics’ Second Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only